Continental Grain led a $39m Series D funding round in DMC Biotechnologies, a a bio-based chemical company, with pariticpation from Toyobo, Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin. “The addition of these strategic investors who have domain experience in nutrition and biobased chemicals, respectively, further enhances our opportunities to serve these market segments. We now have multiple strategic investors on board which validates our accomplishments to date and our potential. We are excited to continue growing the company to its next stage with the support of all of our stakeholders,” Matt Lipscomb, DMC CEO and Co-Founder.